PAA

3.03%

17.0¢ pharmaust limited

Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome, page-172

First 172 Last

Share
Profile

Follow
Cashtrain

1,634 Posts.

579

12/05/20

20:16

Post #: 44582645
Share

Originally posted by adreamer: ↑

How is this for a scenario for the future:

6 out of 7 cancer patients can stave off cancer progression before starting co-treatment, or even live with the cancer without significant degeneration in standard of life.

This could ease pressure on health services and be a saviour for remote and regional families. It could allow families in cities to plan rather then rush instantly into highly invasive, stressful and arduous treatments like chemo etc. It could hold off treatment for patients with other complications.

This was not a fluke. It had full scientific rigour for a second time and got similar and arguably better results. This at least hit my minimum expectation. The formula of pill was successful but the dose needed winding back. The genuine risk of an inconclusive negative outcome is a thing of the past.

Like most I am disappointed in the dog numbers given the timeline and that will be surely discussed at the AGM. If travel allows, I will bring it up so we can comprehend what the heck was the issue and what they could have done better.

I remain confident and just because the trading fluctuated, didn’t hit $ , well so be it. The narrative remains valid. I stay and dream of exciting days ahead. I fully expect it will likely take time. Reading other posts, others have a similar view.

I am not trying to up or down ramp and being honest, the close price was annoyingly / disappointingly low but the market has spoken and that message will not be lost on the BoD - one would expect.

So those venting, suspect we all have some disappointments with you to a degree, but I have no intention of throwing my toys out of the cot. To me, this was confirmation of what we knew with added learnings. The scientific side gained invaluable insights.

So dyor to make your choices and then own your decisions.

just adreamer who will sleep well tonight. Look forward to the future banter.

Expand

Well said mate....we got the Cake ingredients......just need it to be best it can!! .......and it WILL.
MPL a big cake.....even if it’s a slice.....it’s a nice taste now. Definitely will be a slice of the solution, Solely or in Combination........IT BUYS TIME.

PAA Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

EQR

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMD

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

SVL

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

There are more pages in this discussion • 267 more messages in this thread...

First 172 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 17.0¢		Change 0.005(3.03%)		Mkt cap ! $82.65M

Open	High	Low	Value	Volume
17.0¢	18.0¢	16.8¢	$151.1K	877.6K

Buyers (Bids)

No.	Vol.	Price($)
4	54714	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	371375	7

View Market Depth

No.	Vol.	Price($)
4	54714	0.170
6	317468	0.165
6	179000	0.160
4	512800	0.155
8	328999	0.150

Price($)	Vol.	No.
0.180	371375	7
0.185	177426	2
0.190	261458	4
0.195	147632	3
0.200	1055496	11

Last trade - 16.10pm 16/08/2024 (20 minute delay)

PAA (ASX) Chart

Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome, page-172

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome, page-172

Top Stories

EQ Resources transitions historic Mt Carbine tungsten mine to owner-operator system

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 33 Wrap: US recession fears forgotten; RBNZ’s surprise rate cut; more iron ore trouble

Emerald & Azure score Digger & Dealer awards

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

Court of Appeal upholds environmental group's challenge to Silver Mines Ltd's Bowden project

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News